Clinical Trial Update: A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine [Phase 1]

View source ↗

Summary

Phase 1 randomized PK/PD interaction study evaluating potential interactions between TNM002 and Adsorbed Tetanus Vaccine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tetanus

Drugs mentioned

• Adsorbed Tetanus Vaccine (Tetanus toxoid vaccine, adsorbed)
• TNM002

Snippet

Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. | Conditions: Tetanus | Phase 1 | Status: COMPLETED